Bastiano Sanna, EVP, Cell & Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,694 shares at $350.00 ($1.3M) on 2023-05-08, disclosed to the SEC on 2023-05-09.
Scheduled sale ($1.3M) by EVP, Cell & Genetic Therapies under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $350.03 | 422 | $148K | 11.4% |
| 2 | $350.03 | 422 | $148K | 11.4% |
| 3 | $350.00 | 2,850 | $998K | 77.2% |
| Total | $350.01 avg | 3,694 | $1.3M | 100% |
| Filing → |
| VRTX | SELL | 2023-04-06 | $231K | — | Filing → |
| VRTX | SELL | 2023-03-20 | $1.7M | — | Filing → |
| VRTX | SELL | 2023-02-16 | $1.3M | — | Filing → |